Severity Profile of COVID-19 in Hospitalized Pediatric Patients

Vânia Chagas da Costa1,2, Ulisses Ramos Montarroyos1, Katiuscia Araújo de Miranda Lopes2

  • 1Postgraduate Program in Health Sciences, Universidade de Pernambuco, Recife 50100-010, Pernambuco, Brazil.

PubMed

Insights

Children hospitalized with COVID-19 face severe illness risks, especially those with uncontrolled asthma, obesity, cough, or under one year old. Improved asthma and nutrition management are crucial for these pediatric patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • COVID-19 significantly impacts pediatric populations, necessitating understanding of disease severity factors.
  • Hospitalized children with COVID-19 require detailed clinical characterization to guide management.

Purpose of the Study:

  • To identify clinical characteristics associated with severe COVID-19 outcomes in hospitalized children.
  • To analyze risk factors contributing to severe disease in pediatric COVID-19 cases.

Main Methods:

  • An epidemiological cohort study involving 191 children aged 0-14 years hospitalized with COVID-19 between March 2020 and June 2021.
  • Data collected from hospital epidemiology centers and medical records, classifying severity as severe (critical/severe) or non-severe (asymptomatic/mild/moderate).
  • Multivariate analysis used to determine the association between clinical profile and disease severity.

Main Results:

  • 73.3% of hospitalized children developed severe COVID-19.
  • Hypoxemia (oxygen saturation <95%) was observed in 46.6% of cases.
  • Risk factors for severe COVID-19 included uncontrolled asthma (RR=13.2), overweight/obesity (RR=3.21), cough (RR=2.72), and age under one year (RR=3.23).

Conclusions:

  • Children with uncontrolled asthma, overweight/obesity, cough, or under one year old are at higher risk for severe COVID-19.
  • Highlights the need for enhanced healthcare, particularly in managing asthma and nutrition, for vulnerable pediatric COVID-19 patients.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
302
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
211
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
129
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
174
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
225